Guillain-Barré syndrome

Area of Science:

• Neurology
• Critical Care Medicine

Background:

• Guillain-Barré syndrome (GBS) is the leading cause of acute neuromuscular weakness globally.
• Significant variations exist in GBS-related mortality rates across different regions.
• Effective management is crucial, particularly for severe cases requiring intensive care.

Purpose of the Study:

• To provide a comprehensive overview of Guillain-Barré syndrome (GBS) patient care.
• To emphasize the specific management strategies for GBS patients admitted to the intensive care unit (ICU).
• To discuss factors influencing mortality and morbidity in critically ill GBS patients.

Main Methods:

• Literature review focusing on GBS epidemiology, pathophysiology, and clinical management.
• Analysis of current intensive care unit protocols for neuromuscular disorders.
• Synthesis of evidence-based guidelines for respiratory, cardiovascular, and supportive care in GBS.

Main Results:

• GBS management requires a multidisciplinary approach, including respiratory support, hemodynamic monitoring, and early rehabilitation.
• ICU admission is often necessary for patients with respiratory failure or autonomic dysfunction.
• Prognosis is influenced by factors such as age, GBS subtype, and timeliness of intervention.

Conclusions:

• Optimal management of Guillain-Barré syndrome (GBS) in the intensive care unit can significantly improve patient outcomes.
• Early recognition and intervention are key to reducing mortality and long-term disability.
• Continued research is needed to further refine treatment strategies and understand GBS pathophysiology.